Cargando…

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells

The expression of the asialoglycoprotein receptor (ASGP-R) on human hepatocellular carcinoma (HCC) cells might be exploited to reduce the extrahepatic toxicity of DNA synthesis inhibitors by their conjugation with galactosyl-terminating peptides. In the present study we first assessed the frequency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trerè, D, Fiume, L, Giorgi, L Badiali De, Stefano, G Di, Migaldi, M, Derenzini, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362929/ https://www.ncbi.nlm.nih.gov/pubmed/10507763 http://dx.doi.org/10.1038/sj.bjc.6690708

Ejemplares similares

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
por: Nair, Anroop B., et al.
Publicado: (2019)

Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
por: Yousef, Shaimaa, et al.
Publicado: (2018)

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
por: Ahn, Green, et al.
Publicado: (2021)

Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles
por: Li, Yang, et al.
Publicado: (2021)

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor
por: Sun, Rensong, et al.
Publicado: (2021)

Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor
Publicado: (1983)

Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface
Publicado: (1982)

Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells
Publicado: (1982)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma
por: Rumi, M A K, et al.
Publicado: (2001)

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
por: Li, Jun, et al.
Publicado: (2014)

Impact of Asialoglycoprotein Receptor and Mannose Receptor Deficiency on Murine Plasma N-glycome Profiles
por: Svecla, M., et al.
Publicado: (2023)

Receptor-mediated endocytosis of asialoglycoproteins by rat hepatocytes: receptor-positive and receptor-negative endosomes
Publicado: (1986)

Ligand- and weak base-induced redistribution of asialoglycoprotein receptors in hepatoma cells
Publicado: (1987)

Three-Dimensional Models of the Oligomeric Human Asialoglycoprotein Receptor (ASGP-R)
por: Massarelli, Ilaria, et al.
Publicado: (2010)

Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity
por: Roggenbuck, Dirk, et al.
Publicado: (2012)

A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation
por: Christie, Michelle P., et al.
Publicado: (2014)

Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to LPS/Galactosamine Liver Injury and Protection by Betaine Administration
por: Rasineni, Karuna, et al.
Publicado: (2020)

An in vivo Method for Determination of Endosomal Distribution of Both Ligand and Asialoglycoprotein Receptor in Rat Liver
por: Dalton, Shana R, et al.
Publicado: (2004)

The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective
por: Montanaro, Lorenzo, et al.
Publicado: (2013)

Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
por: Brighenti, Elisa, et al.
Publicado: (2015)

Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why
por: Derenzini, Enrico, et al.
Publicado: (2018)

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2001)

Two pathways for the degradation of the H2 subunit of the asialoglycoprotein receptor in the endoplasmic reticulum
Publicado: (1993)

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Hepatocellular carcinoma
por: Giovannini, M, et al.
Publicado: (2001)

Intracellular segregation of asialoglycoproteins and their receptor: a prelysosomal event subsequent to dissociation of the ligand-receptor complex
Publicado: (1984)

Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: biochemical characterization of the endosomal compartments
Publicado: (1985)

Effect of lysosomotropic amines on the secretory pathway and on the recycling of the asialoglycoprotein receptor in human hepatoma cells
Publicado: (1985)

Rat hepatocytes bind to synthetic galactoside surfaces via a patch of asialoglycoprotein receptors
Publicado: (1980)

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
por: Schmidt, Karsten, et al.
Publicado: (2017)

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (1999)

The Ribosome Biogenesis—Cancer Connection
por: Penzo, Marianna, et al.
Publicado: (2019)

Specific capture of glycosylated graphene oxide by an asialoglycoprotein receptor: a strategic approach for liver-targeting
por: Diaz-Galvez, Kevin R., et al.
Publicado: (2019)

Intracellular degradation of unassembled asialoglycoprotein receptor subunits: a pre-Golgi, nonlysosomal endoproteolytic cleavage
Publicado: (1989)

The H1 and H2 polypeptides associate to form the asialoglycoprotein receptor in human hepatoma cells
Publicado: (1988)

A Novel Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting
por: Zhang, Pu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dcu2k8p424846gdc11nvd1kv89